子宫腺肌病组织中MCP-1含量变化及意义
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Changes of monocyte chemoattractant protein-1 content in adenomyotic tissue and its significance
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨单核细胞趋化蛋白-1(monocyte chemoattractant protein-1,MCP-1)在子宫腺肌病发病中的作用。方法 采用免疫组化法和实时荧光定量PCR法检测36例子宫腺肌病患者在位内膜、异位病灶组织中的MCP-1含量,并与相应对照组进行比较。结果 腺肌病患者在位内膜和异位病灶组织MCP-1含量均高于相应正常对照组(P<0.05);异位病灶组织中MCP-1含量高于在位内膜(P<0.05),且两者具有相关性(r=0.87,P<0.01)。结论 MCP-1可能参与了子宫腺肌病的发病过程,但具体分子机制尚需进一步研究。

    Abstract:

    Objective To investigate the role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of adenomyosis. Methods MCP-1 was examined by immunohistochemistry method and real-time PCR in the eutopic endometrium and ectopic endometrium of 36 patients with adenomyosis, and the results were compared with those of controls. Results MCP-1 contents in the eutopic endometrium and ectopic endometrium of patients with adenomyosis were significantly higher than those of normal controls(P<0.05). The contents in ectopic endometrium tissue was significantly higher than that in eutopic endometrium tissue (P<0.05), and the contents in the two tissues were significantly correlated with each other (r=0.87, P<0.01) .Conclusion MCP-1 may be involved in the pathogenesis of adenomyosis, but the specific molecular mechanisms need further study.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2011-10-08
  • 最后修改日期:2012-01-04
  • 录用日期:2012-01-18
  • 在线发布日期: 2012-02-14
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭